- Business Hours:
- Monday – Friday 8:00 am to 6:00 pm
- Pharmacy Business Hours:
- 8:30 am to 5:30 pm
Clinical Trial For People Newly Diagnosed With HIV
We’re excited to announce that we’ve begun enrollment for a new clinical trial for individuals who are either treatment-naive or treatment-experienced but naive to the study drug class. Eligible participants must not have received any antiretroviral therapy (ART) within 12 weeks of screening, including medications used for pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP).
Between 18 and 65 years of age
New diagnosis of HIV-1 Infection or,
Previously diagnosed but not taking any HIV-1 medications for the past 12 weeks
Not pregnant or breastfeeding, and not wish to become pregnant during the study period
Taking part in this study will last about 25 days, not including the initial screening visit to determine qualification. During this time, there are 10 visits to the study site.
Study assessments could include the following:
Collect blood and urine
Physical exams
Vital signs
ECG
Taking an investigational study drug
Investigational study drug provided at no cost
Upon completion of study drug, participants can initiate a Sponsor-provided HIV treatment at no cost for the remainder of the study
Access to care by a doctor and close monitoring of your health during the study
Reimbursement for travel expenses and compensation for participation
Contributing to medical science for HIV
A participating research doctor can give you and/or the subject more information and answer any questions you might have.